小蘖碱
462
2500000s
2000000l

lec fo r1500000ebmuN1000000500000

00
24
48
72
Time (h)
Fig. 1. in the course of 72 h. Concentrations of berberine (µg/ml): control ( ), 0.001 (■), 0.01 (▲), 0.1 (×), 1 (ж), 5 ( ), 10 (+), 25 (□). Each point represents the mean ± SD of three experiments.
3,5)
lm( 3emu2,5lov r2omu1,5

t ega1revA0,50
K
1
5
10
Treatment group
Fig. 3. Growth of tumors after intramuscular injection of
B16 cells. Mice were intraperitoneally treated with carboxymethylcellulose as control (C) and berber-ine at concentrations of 1 (1), 5 (5) and 10 (10) mg/kg. The animals were measured on day 0, 5, 9, 12 and 16. Data represent the arithmetic means ± SE. Statistically signi cant di erences with P < 0.05 are indicated with *.
The data from in vitro and in vivo study were presented as means ± s.e. (standard errors). The statistical signi -cance of the results was evaluated by Student’s t-test, with probability values of 0.05 being considered as signi cant. RESULTS AND DISCISSION
The growth of B16 cells exposed to berberine at con-centrations ranging from 0.001 to 25 µg/ml was moni-tored within 72 h of culturing (Fig. 1). As shown in Fig. 1, the addition of berberine to the medium reduced the B16 viable cell number. After 24 h, the highest tested concen-trations (25, 10 and 5 µg/ml) had an acute cytotoxic e ect S. Leta iová, S. Jantová, M. Mú ková, M. Theiszová


of B16 cells. Mice were intraperitoneally treated with carboxymethylcellulose as control (C) and tested compound, berberine, at concentrations of 1 (1), 5 (5) and 10 (10) mg/kg. The animals were weighed on day 0, 5, 9, 12 and 16. Data represent the arithmetic means ± SE. Statistically signi cant di erences with P < 0.05 are indicated with *.
Fig. 4. Weight of tumors formed in mice 16 days after in-tramuscular injection of B16 cells. C57BL/6 mice were intraperitoneally treated with carboxymethyl-cellulose as control (C) and berberine at concentra-tions of 1,5 and 10 mg/kg. Data represent the means ± SE.
manifested by partial degeneration of the B16 cell popula-tions. Berberine at concentrations of 1 µg/ml for the B16 cells induced a delayed cytotoxic e ect. After 24 h, part of the cell population proliferated, but after 48 h, 64.9 % of the cell degeneration was observed. The cytotoxic ef-fect of berberine at the next tested concentrations (0.1, 0.01 and 0.001 µg/ml) was directly proportional to the concentration and the time of in uence. The inhibition of cell proliferation was 32.7–86.1 %. These changes in viable cell number were also observed when aliquots of the cultures were examined by light microscopy.
The weight of the animals treated with 1, 5 and 10 mg/kg in comparison with control is shown in Fig. 2. The injected animals were weighed twice per week, on
黑色素瘤介绍 主要内容 1 2 3 4 黑色素瘤形成与发病机制 黑色素瘤临床表现 治疗与预后 黑色素瘤(melanoma) 黑色素瘤是一种能产生黑色素的高度恶性肿瘤,又称...
黑人少见。编辑本段分类 构成所有的恶性黑色素瘤只有一种恶性细胞类型,即被称作黑色素细胞的恶性色素产生细胞,但它们通过其形态,如梭形、圆柱形,而存在一些很少的...
19 ? 5 中 国黑 色素瘤诊治指南(0 )21 1版 CC黑 色素 瘤专 家委 员会 SO 【 关键词 】 恶性黑色素瘤 ;中国; 诊断; 治疗 ; 指南 中图分类号:795...
部分恶黑呈现皮肤色,又叫作 无色素的恶性黑素瘤。 欧美高加索白种人最常见的是浅表扩散型恶性黑素瘤, 主要分布于躯干和四肢, 从病理上看 主要是以水平侵袭为主...
http://www.qiuyi.cn/ 黑色素瘤的预防方法有哪些黑色素瘤 60%是由黑痣恶变的,因此如果发现身体各个部位的小黑痣出现增大、颜色 加深, 边缘不规则,甚至发痒、破...
恶性黑色素瘤_临床医学_医药卫生_专业资料。恶性黑色素瘤 (malignant melanoma,MM) 目录一、 二、 三、 四、 五、 六、 七、 八、 九、 概述 流行病学与...
赴美就医-黑色素瘤患者的福音_临床医学_医药卫生_专业资料。我现在已经开始了我的新生活。毕竟,我经历过了癌症 - 我自己的癌还有简的- 我把自己训练成为一名...
黑色素瘤_临床医学_医药卫生_专业资料。恶性黑色素瘤是一种产生黑色素的高度恶性肿瘤,仅少数为无色素恶性黑色素瘤。发病率为全部恶性肿瘤的1%-3%,近年有上升...
NRAS突变的黑色素瘤分子机制研究进展_医药卫生_专业资料。NRAS 突变的黑色素瘤分子机制研究进展 【摘要】NRAS 突变的黑色素瘤中有一些经典的信号通路,与肿瘤的...
热门文档